Symbollon Pharmaceuticals Inc.
37 Loring Drive
Framingham,
MA 01702
United States - Map
Phone: 508-620-7676
Fax: 978-443-0166
Web Site: http://www.symbollon.com
| Symbollon Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of proprietary products based on its molecular iodine technology for women's healthcare and antimicrobials uses. It develops proprietary iodine technology that maximizes the therapeutic index of iodine that has applications in womens healthcare and infection control. The company also develops IoGen tablet, an oral dosage form, which completed phase III clinical trials that generates molecular iodine in situ in the stomach of the patient. It serves hospitals, medical offices, dental offices, dialysis centers, outpatient clinics, and nursing homes. The company was formerly known as Symbollon Corporation and changed its name to Symbollon Pharmaceuticals, Inc. in 2001. The company was founded in 1986 and is based in Framingham, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Paul C. Desjourdy , 47
Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer, Treasurer, Assistant Sec., Gen. Counsel, Director and Member of Exec. Committee |
N/A
| N/A | Mr. David Jones , 49
Exec. VP |
N/A
| N/A | Dr. Yongjun Duan ,
VP of Asian Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.28% Nasdaq 
Profile
